510(k) Report

FDA product code · Cardiovascular

Heart-Valve, Mechanical

LWQClass IIIPMA required9 decisions since 19812 recalls

9 FDA decisions since 1981. 2 recalls name this code, 0 of them Class I.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, cardiovascular panel

Twenty years of LWQ at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · LWQ

9in 2025

2007: 122008: 152009: 82010: 62011: 162012: 212013: 172014: 112015: 142016: 132017: 112018: 82019: 42020: 62021: 92022: 82023: 92024: 62025: 92026 (partial year): 5
2007high 21 (2012) · low 4 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LWQ

Too few LWQ 510(k)s in any year since 2007 to give a median.

Recalls per year · LWQ

1so far in 2026, the most since 2007

2026 (partial year): 1
2007high 1 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LWQ

330in 2025

2007: 882008: 902009: 912010: 1192011: 1392012: 1222013: 1342014: 1342015: 1392016: 2022017: 2992018: 4342019: 3502020: 3722021: 2872022: 2972023: 4552024: 4042025: 330
2007high 455 (2023) · low 88 (2007)2025

MAUDE reports naming product code LWQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200712—088
200815—090
20098—091
20106—0119
201116—0139
201221—0122
201317—0134
201411—0134
201514—0139
201613—0202
201711—0299
20188—0434
20194—0350
20206—0372
20219—0287
20228—0297
20239—0455
20246—0404
20259—0330
20265—1—
FIG. 1 — LWQ by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in LWQ? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report